Dr. Seth F. Tatel, MD

Dr. Tatel practices at Northwestern Medicine McHenry Hospital in Mchenry, Illinois, part of Northwestern Memorial HealthCare.

Dr. Tatel's NPI, 1144433467, was assigned on May 7, 2007. Dr. Tatel holds Wisconsin license 3294.

Dr. Tatel's primary practice is Northwestern Medicine McHenry Hospital, at 4201 Medical Center Drive, Mchenry, IL 60050 in Mc Henry County. The practice phone is (815) 344-5000.

Dr. Tatel's primary practice is Northwestern Medicine McHenry Hospital in Mchenry, Illinois, part of Northwestern Memorial HealthCare. Dr. Tatel is also affiliated with Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Tatel to 1 more hospital, 7 medical groups and 6 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tatel practices, 9 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Tatel's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Tatel's licenses on file in 3 states: Wisconsin, Illinois and Indiana.

CMS data shows 64 Medicare services from Dr. Tatel across 3 procedure codes in 2024, for 61 Medicare patients. Medicare paid $2,115 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 61 Medicare patients who saw Dr. Tatel in 2024. The largest group is 65 to 74, with 25 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tatel's median patient age at 74, with 53% women.

In 2024, Dr. Tatel wrote 265 Medicare Part D claims for 90 patients. 83% of them were for generic drugs. CMS names the drug for 134 of them, across 7 drugs with 11 or more claims each, at $15,206 in total drug cost. In 2023, CMS named 1,047 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Tatel for performance year 2024, reported as part of a group. Dr. Tatel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 189 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Tatel, more than 89% of the clinicians it reports for that procedure.

CMS Open Payments shows 565 general payments to Dr. Tatel from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Abbvie Inc. paid the most, $3,474.